CBPO [China Biologic Products] SC 13D/A: JOINT FILING AGREEMENT Agreement 1. Each person executing

Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: SC 13D/A, Date: 2020-04-08
Original SEC Filing: Click here


Webplus: CBPO/20200408/SC_13D.A_2/2_EX-99.1/000.htm SEC Original: tm2015361d1_ex1.htm
JOINT FILING AGREEMENT Agreement 1. Each person executing this Agreement is responsible for the timely filing of such Schedule 13D and any subsequent amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but no person executing this Agreement is responsible for the completeness or accuracy of the information concerning any other persons making




Webplus: CBPO/20200408/SC_13D.A_2/3_EX-5/000.htm SEC Original: tm2015361d1_ex5.htm
Execution Version USD350,000,000 Revolving Facilities Agreement CITIC CAPITAL CHINA PARTNERS IV, L.P. as Borrower CCP IV GP LTD. as General Partner and Société Générale, Hong Kong Branch as Lender 16 January CONTENTS CLAUSE PAGE 1. definitions and INTERPRETATION 4 2. THE FACILITIES 23 3. PURPOSE 23 4. CONDITIONS OF UTILISATION 24 5. extension OPTION 24 6. UTILISATION – Loans 25




Webplus: CBPO/20200408/SC_13D.A_2/1/000.htm SEC Original: tm2015361-1_sc13da.htm



Company Info:

Ticker: CBPO, Company: China Biologic Products Holdings, Inc., Type: SC 13D/A, Date: 2020-04-08CIK: 0001369868, Location: F4, SIC: 2836, SIC Desc: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Phone & Address:
18TH FL, JIALONG INTERNATIONALBUILDING, 19 CHAOYANG PARK ROAD, CHAOYANG DISTRICT
BEIJING 100125

Home Page Forums

About the Author:

Leave A Comment

Skip to toolbar